Panalgo Evidence Generation Services
Powered by IHD, our real-world evidence and analytics services will be your guide on the analytics journey.
Analytics Services:
Our solutions are flexible and scalable to meet your evolving analytics needs and include project implementation, study expertise, staff augmentation, and data support.
Professional Services:
Need a fast track to actionable evidence? We meet you where you are in your evidence generation journey and get you where you need to go, providing expertise for HEOR, RWE, epidemiology, regulatory, and market access teams.
Analytics Services
Project Implementation (Simple)
Need quick answers to high level questions? Low commitment, high reward.
Project Implementation (Complex)
Have a more complex request such as structured feasibility and assessment of fit-for-purpose data? Our team implements a single, well-defined analysis plan in IHD for you to inform go/no go decisions.
Scientific/Full Study Expertise
Let us guide you at every step of your analysis and leverage our team of experienced researchers and analysts to help you conceptualize and implement your project.
Staff Augmentation
A Panalgo expert joins your team to implement analyses in IHD for discrete projects or on an ongoing basis. Let us augment your staff resources to get more analyses done, more quickly.
RWD Support & Curation
Our experts work with you to get the most out of a data source, like aiding in creating an analytic dataset or understanding a new data source.
Professional Services
HEOR / RWE Teams
We bring expertise in HEOR, epidemiology, biostatistics, and data science to your real-world studies. We handle everything from study design and feasibility testing, protocol writing, study management, interpretation, reporting, through publication. Our IHD platform is 85% faster than traditional programming methods.
Regulatory Grade Evidence
Panalgo offers a transparent, auditable, and scalable platform for generating regulatory-grade evidence, such as external control arms, RWE for label expansion and post-marketing safety surveillance. IHD has been used to expedite responses to agencies such as FDA, EMA, and PMDA (Japan).
Epidemiology Studies
Our epidemiologists and biostatisticians can quickly generate incidence and prevalence estimates and inputs for global economic models. We can also conduct risk/benefit and post-marketing safety studies on your behalf. Our IHD platform is scalable to meet the needs of your enterprise.
Market Access / Commercialization Activities
As a Norstella company, we have access to a deep bench of drug commercialization and market access experts. Whether you’re looking to understand patient journey, formulary access and barriers, market segmentation, or drug launch forecast and performance, we can help.
The Panalgo Difference
Powered by IHD
- Our services and experts leverage the IHD platform for fast, flexible, and transparent analytics.
- IHD takes the guess work out of disparate data models and allows us to inform quick, data-driven decisions on feasibility, cohort design, and outcomes measurement.
- IHD has an extensive set of use cases, templates, and measures ready to go.
Flexibility
- Contract for a single project or dedicated support on an ongoing basis (asset, therapy area, business unit or enterprise level).
- We’re data agnostic with deep expertise in closed and open claims, EMR, laboratory, and curated datasets. Leverage our in-house data, partner data, or bring your own.
- Let us grow with you and your needs over time. Get started with Panalgo and add capabilities and tools as needed.
Quality Expertise
- Get dedicated support from our research leaders and analytic consultants, who hold a minimum of a master’s degree, and bring expertise in HEOR, epidemiology, biostatistics, and data science.
Transparency
- We ensure transparency and accountability from start to finish, through direct communication with your dedicated Panalgo delivery team to comprehensive documentation and audit trails.
Leverage Panalgo Services Across the Product Life Cycle
Panalgo services are designed to meet your unique needs. Here’s a peek at just some of the questions we can help you answer.
Discovery
- What is the profile of my target population?
- What is the unmet clinical need?
- Are there new drug pathways to explore?
Development
- How can I strengthen my clinical trial design and recruitment strategy using RWD?
- What does the patient journey look like?
- What is driving healthcare resource utilization and cost?
Launch
- What does treatment utilization look like in the real-world setting?
- How does intervention A compare to intervention B?
- What are the predictors of clinical and economic outcomes?
Lifecycle
- What is the value proposition to payers?
- How does this product compare in effectiveness to others on the market?
- Are there new indications arising through real-world use?